Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malaria

  Free Subscription


10.06.2019

1 Exp Parasitol
1 Lancet
1 Malar J
1 N Engl J Med
1 PLoS Med
3 PLoS One
1 Trans R Soc Trop Med Hyg
1 Trends Parasitol
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Exp Parasitol

  1. YAMAMOTO K, Takahashi K, Ato M, Iwanaga S, et al
    Antimalarial activity of vitamin D3 (VD3) does not result from VD3-induced antimicrobial agents including nitric oxide or cathelicidin.
    Exp Parasitol. 2019;201:67-77.
    PubMed     Text format     Abstract available


    Lancet

  2. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed     Text format    


    Malar J

  3. AIDE P, Candrinho B, Galatas B, Munguambe K, et al
    Setting the scene and generating evidence for malaria elimination in Southern Mozambique.
    Malar J. 2019;18:190.
    PubMed     Text format     Abstract available


    N Engl J Med

  4. WANG J, Xu C, Liao FL, Jiang T, et al
    A Temporizing Solution to "Artemisinin Resistance".
    N Engl J Med. 2019;380:2087-2089.
    PubMed     Text format    


    PLoS Med

  5. KENANGALEM E, Poespoprodjo JR, Douglas NM, Burdam FH, et al
    Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.
    PLoS Med. 2019;16:e1002815.
    PubMed     Text format     Abstract available


    PLoS One

  6. CHAKRAVARTY S, Mandal RK, Duff ML, Yuan F, et al
    Correction: Intestinal short-chain fatty acid composition does not explain gut microbiota-mediated effects on malaria severity.
    PLoS One. 2019;14:e0218250.
    PubMed     Text format     Abstract available

  7. MPIMBAZA A, Nayiga S, Ndeezi G, Rosenthal PJ, et al
    Understanding the context of delays in seeking appropriate care for children with symptoms of severe malaria in Uganda.
    PLoS One. 2019;14:e0217262.
    PubMed     Text format     Abstract available

  8. FINDA MF, Moshi IR, Monroe A, Limwagu AJ, et al
    Linking human behaviours and malaria vector biting risk in south-eastern Tanzania.
    PLoS One. 2019;14:e0217414.
    PubMed     Text format     Abstract available


    Trans R Soc Trop Med Hyg

  9. ELGORAISH AG, Elzaki SEG, Ahmed RT, Ahmed AI, et al
    Epidemiology and distribution of Plasmodium vivax malaria in Sudan.
    Trans R Soc Trop Med Hyg. 2019 Jun 4. pii: 5510701. doi: 10.1093.
    PubMed     Text format     Abstract available


    Trends Parasitol

  10. COELHO CH, Rappuoli R, Hotez PJ, Duffy PE, et al
    Transmission-Blocking Vaccines for Malaria: Time to Talk about Vaccine Introduction.
    Trends Parasitol. 2019 May 29. pii: S1471-4922(19)30084.
    PubMed     Text format     Abstract available


    Vaccine

  11. CAWLFIELD A, Genito CJ, Beck Z, Bergmann-Leitner ES, et al
    Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ).
    Vaccine. 2019 May 28. pii: S0264-410X(19)30696.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: